Publications | Page 339 | Pathology & Laboratory Medicine

Filter By Faculty

Filter by Principal Investigator

2009

Martinez JL, Fajardo A, Garmendia L, Hernandez A, Linares JF, Martínez-Solano L, et al. A global view of antibiotic resistance. FEMS Microbiol Rev. 2009;33(1):44-65.

Cerchietti LC, Yang SN, Shaknovich R, Hatzi K, Polo JM, Chadburn A, et al. A peptomimetic inhibitor of BCL6 with potent antilymphoma effects in vitro and in vivo. Blood. 2009;113(15):3397-405.

Galvez AS, Duran A, Linares JF, Pathrose P, Castilla EA, Abu-Baker S, et al. Protein kinase Czeta represses the interleukin-6 promoter and impairs tumorigenesis in vivo. Mol Cell Biol. 2009;29(1):104-15.

Robinson BD, Jones JG. Tumor microenvironment of metastasis (TMEM): a novel tissue-based assay for metastatic risk in breast cancer. Future Oncol. 2009;5(7):919-21.

Reszko AE, Magro CM, Diktaban T, Sadick NS. Histological comparison of 1064 nm Nd:YAG and 1320 nm Nd:YAG laser lipolysis using an ex vivo model. J Drugs Dermatol. 2009;8(4):377-82.

Ma Q, Cavallin LE, Yan B, Zhu S, Duran EM, Wang H, et al. Antitumorigenesis of antioxidants in a transgenic Rac1 model of Kaposi's sarcoma. Proc Natl Acad Sci U S A. 2009;106(21):8683-8.

Shim J-, Greenblatt MB, Xie M, Schneider MD, Zou W, Zhai B, et al. TAK1 is an essential regulator of BMP signalling in cartilage. EMBO J. 2009;28(14):2028-41.

Rosen CA, Amin MR, Sulica L, C Simpson B, Merati AL, Courey MS, et al. Advances in office-based diagnosis and treatment in laryngology. Laryngoscope. 2009;119 Suppl 2:S185-212.

Cohn CS, Cushing MM. Oxygen therapeutics: perfluorocarbons and blood substitute safety. Crit Care Clin. 2009;25(2):399-414, Table of Contents.

Fernández-Hernando C, József L, Jenkins D, Di Lorenzo A, Sessa WC. Absence of Akt1 reduces vascular smooth muscle cell migration and survival and induces features of plaque vulnerability and cardiac dysfunction during atherosclerosis. Arterioscler Thromb Vasc Biol. 2009;29(12):2033-40.